San Diego based ResMed Corp said the Munich District Court entered preliminary injunctions against Apex Medical Corp and BMC Medical “against several patent infringing activities.”
The initial orders, entered by the Munich District Court, prohibit APEX and BMC from selling or marketing certain products in Germany without a further court order. Those products effected by the rulings are:
- The APEX WiZARD 210 and WiZARD 220 mask headgear
- BMC’s RESmart CPAP devices
- BMC’s Willow/FeaLite nasal pillows patient interface
ResMed has also filed patent infringement lawsuits in Munich, Germany, seeking damages and permanent injunctions to stop infringement of ResMed patents by the products listed above, as well as the additional products below:
- The APEX iCH and XT Fit CPAP devices
- The APEX WiZARD 210 and WiZARD 220 masks
“ResMed has a global business built on its investment in research and development, resulting in products that excel in performance, quality and comfort,” general counsel David Pendarvis said in prepared remarks. “We will continue to defend our investment in intellectual property and pursue all legal remedies to prevent infringement in any country where that infringement exists.”
The post Legal action initiated by ResMed against APEX and BMC Medical appeared first on Sleep Diagnosis and Therapy.
